Einsatz einer perkutanen Impella CP im kardiogenen Schock

Der Einsatz eines perkutanen linksventrikulären Unterstützungssystems (pLVAD) eröffnet die Möglichkeit einer effektiven Kreislaufunterstützung im kardiogenen Schock. Mit einem Spitzenfluss von bis zu 4,3 l/min wird ein linksventrikuläres Unloading, eine bessere Systemperfusion und Oxygenierung erreicht. Dieser Beitrag gibt eine Übersicht über aktuelle Strategien im kardiogenen Schock und das optimale Management auf der Intensivstation.

Schlüsselwörter

Herzpumpe - Impella - pLVAD - kardiogener Schock - akuter Myokardinfarkt - AMI-CS

• Literatur

• 1 Mehta A, Vavilin I, Nguyen AH. et al. Contemporary approach to cardiogenic shock care: a state-of-the-art review. Front Cardiovasc Med 2024; 11: 1354158
• 2 Baran DA, Grines CL, Bailey S. et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv 2019; 94: 29-37
• 3 Naidu SS, Baran DA, Jentzer JC. et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 2022; 79: 933-946
• 4 Baran DA, Long A, Badiye AP. et al. Prospective validation of the SCAI shock classification: Single center analysis. Catheter Cardiovasc Interv 2020; 96: 1339-1347
• 5 Kapur NK, Kanwar M, Sinha SS. et al. Criteria for Defining Stages of Cardiogenic Shock Severity. J Am Coll Cardiol 2022; 80: 185-198
• 6 Saxena A, Garan AR, Kapur NK. et al. Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation 2020; 141: 1184-1197
• 7 Ceglarek U, Schellong P, Rosolowski M. et al. The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction. Eur Heart J 2021; 42: 2344-2352
• 8 Hamann J, Schmidt F, Ibrahim K. Der Einsatz einer perkutanen Impella CP im Rahmen von komplexen Hochrisiko-Koronarinterventionen. Kardiologie up2date 2024; 20: 45-63
• 9 Fincke R, Hochman JS, Lowe AM. et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004; 44: 340-348
• 10 Bertoldi LF, Montisci A, Westermann D. et al. From medical therapy to mechanical support: strategies for device selection and implantation techniques. Eur Heart J Suppl 2023; 25: I11-I18
• 11 Balthazar T, Vandenbriele C, Verbrugge FH. et al. Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week. J Am Coll Cardiol 2021; 77: 1243-1256
• 12 Thiele H, Zeymer U, Akin I. et al. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. N Engl J Med 2023; 389: 1286-1297
• 13 Saito S, Shibasaki I, Matsuoka T. et al. Impella support as a bridge to heart surgery in patients with cardiogenic shock. Interact Cardiovasc Thorac Surg 2022; 35: ivac088
• 14 Zaky M, Nordan T, Kapur NK. et al. Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients. ASAIO J 2023; 69: e158-e162
• 15 Kapur NK, Kim RJ, Moses JW. et al. Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial. Am Heart J 2022; 254: 122-132
• 16 Møller JE, Kjaergaard J, Terkelsen CJ. et al. Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock. J Clin Med 2022; 11: 2427
• 17 Napp LC, Westenfeld R, Møller JE. et al. Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis. Cardiovasc Revasc Med 2022; 40: 113-119
• 18 Stiermaier T, Eitel C, Desch S. et al. Incidence, determinants and prognostic relevance of cardiogenic shock in patients with Takotsubo cardiomyopathy. Eur Heart J Acute Cardiovasc Care 2016; 5: 489-496
• 19 Tschöpe C, Van Linthout S, Klein O. et al. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts. J Cardiovasc Transl Res 2019; 12: 116-123
• 20 Vandenbriele C, Baldetti L, Beneduce A. et al. Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery. Eur Heart J Suppl 2023; 25: I24-I31
• 21 Scolari FL, Schneider D, Fogazzi DV. et al. Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study. BMC Cardiovasc Disord 2020; 20: 496
• 22 Binanay C, Califf RM, Hasselblad V. et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294: 1625-1633
• 23 Richard C, Warszawski J, Anguel N. et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003; 290: 2713-2720
• 24 Garan AR, Kanwar M, Thayer KL. et al. Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality. JACC Heart Fail 2020; 8: 903-913
• 25 Thayer KL, Zweck E, Ayouty M. et al. Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock. Circ Heart Fail 2020; 13: e007099
• 26 Bernhardt AM, Potapov E, Vandenbriele C. et al. Differential utilization of Impella devices, extracorporeal membrane oxygenation, and combined therapies as escalation and de-escalation strategies. Eur Heart J Suppl 2023; 25: I32-I38
• 27 Mazurek R, Kariya T, Sakata T. et al. Negative Impact of Acute Reloading after Mechanical Left Ventricular Unloading. J Cardiovasc Transl Res 2024; 17: 233-241
• 28 Seyfarth M, Sibbing D, Bauer I. et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588
• 29 Møller JE, Engstrøm T, Jensen LO. et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med 2024; 390: 1382-1393